can you switch back and forth between semaglutide and tirzepatide Switching from to Tirzapetide Dosing : r/tirzepatidecompound Switching From Semaglutide To Tirzepatide

The most commonly reported side effects include: Nausea : Affecting 12% to 24% of patients with type 2 diabetes and 24% to 31% in weight management trials [1] [14] Diarrhea : 12% to 17% in diabetes trials and 18% to 23% in weight management trials Decreased appetite : 5% to 10% of patients Vomiting : 5% to 10% in diabetes trials and 8% to 12% in weight management trials Constipation : 5% to 7% in diabetes trials and 16% to 17% in weight management trials Dyspepsia : 5% to 9% of patients Abdominal pain : 5% to 9% of patients Alopecia (hair loss) : Reported in weight management trials These symptoms are typically mild to moderate in severity, occur most commonly during dose escalation, and tend to diminish over time as patients develop tolerance

Louis Aronne at Weill Cornell Medicine)

Novo Nordisk holds protection until 2032 in the United States and until 2031 in both Japan and Europe, according to its annual report

Davies et al, 2018